Krystal Biotech (KRYS) PT Raised to $403 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $310.84 +1.90%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
TD Cowen analyst Ritu Baral raised the price target on Krystal Biotech (NASDAQ: KRYS) to $403.00 (from $306.00) while maintaining a Buy rating.
You May Also Be Interested In
- Krystal Biotech (KRYS) PT Lowered to $380 at TD Cowen
- Nomad Foods Ltd (NOMD) PT Raised to $15 at Jefferies
- Avis Budget Group (CAR) PT Lowered to $125 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
